Rani Therapeutics Holdings Inc (RANI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $60.78M
Last updated: Nov 17, 2026 at 11:05 AM ET
Rani Therapeutics Holdings Inc (RANI) Earnings: Report Dates and Results
Rani Therapeutics Holdings (RANI) is expected to report earnings on Mar 25, 2027. In the quarter ended Sep 30, 2026, Rani Therapeutics Holdings reported EPS of -$0.04, above the -$0.05 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
RANI has an expected report date of Mar 25, 2027.
Earnings History
Of the 23 quarters below that had an estimate, RANI beat 17, missed 3 and matched 3. The widest gap in the table came in the quarter ended Mar 31, 2022, when EPS landed 56.06% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.04 | -$0.05 | -$0.05 - -$0.04 | +20.00% | Beat | N/A | 3 | 1 up, 0 down | Nov 9, 2026 | $1.71M |
| Jun 30, 2026 | -$0.04 | -$0.05 | -$0.05 - -$0.05 | +20.00% | Beat | N/A | 3 | 1 up, 0 down | Aug 13, 2026 | $1.71M |
| Mar 31, 2026 | -$0.04 | -$0.04 | -$0.06 - -$0.02 | 0.00% | In line | N/A | 4 | 1 up, 0 down | May 15, 2026 | $1.71M |
| Dec 31, 2025 | -$0.07 | -$0.05 | -$0.14 - -$0.01 | -47.37% | Miss | N/A | 3 | 1 up, 1 down | Mar 26, 2026 | $1.46M |
| Sep 30, 2025 | -$0.12 | -$0.12 | -$0.15 - -$0.09 | 0.00% | In line | N/A | 3 | 2 up, 0 down | Nov 6, 2025 | N/A |
| Jun 30, 2025 | -$0.18 | -$0.19 | -$0.20 - -$0.19 | +5.26% | Beat | N/A | 2 | 0 up, 0 down | Aug 7, 2025 | N/A |
| Mar 31, 2025 | -$0.22 | -$0.24 | -$0.24 - -$0.24 | +8.33% | Beat | N/A | 1 | 0 up, 0 down | May 13, 2025 | $172000 |
| Dec 31, 2024 | -$0.27 | -$0.26 | -$0.28 - -$0.17 | -3.85% | Miss | N/A | 3 | 1 up, 0 down | Mar 31, 2025 | $1.03M |
| Sep 30, 2024 | -$0.24 | -$0.29 | -$0.34 - -$0.25 | +17.24% | Beat | N/A | 3 | 1 up, 0 down | Nov 14, 2024 | N/A |
| Jun 30, 2024 | -$0.26 | -$0.29 | -$0.55 - -$0.22 | +10.34% | Beat | N/A | 7 | 0 up, 0 down | Aug 6, 2024 | N/A |
| Mar 31, 2024 | -$0.29 | -$0.23 | -$0.24 - -$0.14 | -26.09% | Miss | N/A | 3 | 0 up, 0 down | May 6, 2024 | N/A |
| Dec 31, 2023 | -$0.27 | -$0.31 | -$0.37 - -$0.24 | +12.90% | Beat | N/A | 5 | 0 up, 0 down | Mar 20, 2024 | $2.75M |
| Sep 30, 2023 | -$0.36 | -$0.37 | -$0.42 - -$0.30 | +2.70% | Beat | N/A | 6 | 0 up, 0 down | Nov 8, 2023 | N/A |
| Jun 30, 2023 | -$0.37 | -$0.42 | -$0.71 - -$0.33 | +11.90% | Beat | N/A | 7 | 0 up, 0 down | Aug 11, 2023 | N/A |
| Mar 31, 2023 | -$0.33 | -$0.43 | -$0.69 - -$0.33 | +23.26% | Beat | N/A | 6 | 0 up, 0 down | May 10, 2023 | N/A |
| Dec 31, 2022 | -$0.35 | -$0.35 | -$0.54 - -$0.17 | 0.00% | In line | N/A | 5 | 0 up, 0 down | Mar 22, 2023 | N/A |
| Sep 30, 2022 | -$0.33 | -$0.62 | -$0.73 - -$0.31 | +46.77% | Beat | N/A | 5 | 0 up, 0 down | Nov 10, 2022 | N/A |
| Jun 30, 2022 | -$0.31 | -$0.67 | N/A | +53.73% | Beat | N/A | N/A | 0 up, 0 down | Aug 10, 2022 | N/A |
| Mar 31, 2022 | -$0.29 | -$0.66 | -$1.00 - -$0.32 | +56.06% | Beat | N/A | 2 | 0 up, 0 down | May 11, 2022 | N/A |
| Dec 31, 2021 | -$0.67 | -$1.28 | -$1.28 - -$0.22 | +47.66% | Beat | N/A | 4 | 0 up, 0 down | Mar 29, 2022 | N/A |
| Sep 30, 2021 | -$0.13 | -$0.20 | -$0.22 - -$0.15 | +35.00% | Beat | N/A | 5 | N/A | Nov 15, 2021 | N/A |
| Jun 30, 2021 | -$0.12 | -$0.18 | -$0.24 - -$0.13 | +33.33% | Beat | N/A | 5 | 0 up, 0 down | Aug 2, 2021 | $1.96M |
| Mar 31, 2021 | -$0.12 | -$0.12 | N/A | +4.17% | Beat | N/A | N/A | N/A | Jun 2, 2021 | $756000 |
| Dec 31, 2020 | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2021 | $210000 |
| Dec 31, 2019 | -$0.11 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2020 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.59, after -$1.06 the year before. It was -$0.11 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.59 | N/A |
| Dec 31, 2024 | -$1.06 | N/A |
| Dec 31, 2023 | -$1.33 | N/A |
| Dec 31, 2022 | -$1.28 | N/A |
| Dec 31, 2021 | -$1.04 | N/A |
| Dec 31, 2020 | -$0.12 | N/A |
| Dec 31, 2019 | -$0.11 | N/A |
Frequently Asked Questions About RANI
When is Rani Therapeutics Holdings's next earnings date?
Rani Therapeutics Holdings's next earnings report is expected for Mar 25, 2027.
Did RANI beat earnings estimates last quarter?
Yes. Rani Therapeutics Holdings reported EPS of -$0.04 for the quarter ended Sep 30, 2026, above the -$0.05 estimate, a 20.00% surprise.
What EPS do analysts expect from RANI next quarter?
The consensus EPS estimate for Rani Therapeutics Holdings for the quarter ending Dec 31, 2026 is -$0.05 from 7 analysts, with estimates from -$0.06 to -$0.04.
How often does RANI beat earnings estimates?
Rani Therapeutics Holdings beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +0.30%.
RANI pages: Overview, Earnings, Forecast, Financials, Competitors